Clinical Trial Update: Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML [Phase 2]

View source ↗

Summary

This clinical trial update concerns a Phase 2 study of BP1001 in combination with venetoclax and decitabine for acute myeloid leukemia, which is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BP1001
• Decitabine (Decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: Bio-Path Holdings, Inc. | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: RECRUITING